2006

1. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: Report of the thirty-person/ten-country panel

   Journal of Internal Medicine, Vol. 259, Núm. 3, pp. 247-258

2. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study

   Lancet, Vol. 368, Núm. 9539, pp. 919-928